|
Dr. Luiz Belardinelli is Senior Vice President of Pharmacology and Translational Biomedical Research and a Distinguished Fellow of Cardiovascular Science. Before joining CV Therapeutics in 1999, Dr. Belardinelli was Professor of Medicine in the Divisions of Cardiology and Pharmacology at the University of Florida, where he was the Eminent Scholar Chair in Cardiovascular Research. Dr. Belardinelli has helped elucidate the mechanism of action of late sodium current inhibition, defined the role of cardiac adenosine receptor subtypes, and pioneered the use of adenosine in the treatment of supraventricular tachycardia.
Internationally recognized as an expert in adenosine physiology and pharmacology, Dr. Belardinelli has received awards such as the Inventor of the Year Award from the University of Virginia (1992), the Dr. Harold Lamport Award of the American Physiology Society Cardiovascular Section (1984), and the Young Investigator Award of the 11th Interamerican Congress of Cardiology (1980). He has authored over 160 journal articles and book chapters and more than 20 U.S. patents.
Dr. Belardinelli received his MD from the Medical Catholic School of Pôrto Alegre, Brazil and completed a four-year postdoctoral research fellowship in the Department of Physiology at the University of Virginia. | 